cor 145
Pill imprint cor 145 has been identified as Benztropine mesylate 2 mg.
Benztropine is used in the treatment of parkinson's disease; extrapyramidal reaction and belongs to the drug class anticholinergic antiparkinson agents. FDA has not classified the drug for risk during pregnancy.
Benztropine 2 mg is not subject to the Controlled Substances Act.
See also related documents.
Benztropine mesylate Images
- Imprint:
-
cor 145
- Strength:
- 2 mg
- Color:
- White
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- magnesium stearate
microcrystalline cellulose
povidone
corn starch
- Drug Class:
- Anticholinergic antiparkinson agents
- Pregnancy Category:
- N - Not yet classified
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Rising Pharmaceuticals, Inc.
- National Drug Code (NDC):
- 64980-0113
| NDC Code | Manufacturer / Repackager |
|---|---|
| 00904-1057 | Major Pharmaceuticals |
| 64720-0145 | Core Pharmaceuticals Inc |
| 21695-0286 | Rebel Distributors Corp (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Benztropine Mesylate resources
- Benztropine (Wolters Kluwer)
- Benztropine Tablets (Wolters Kluwer)
- benztropine (Cerner Multum)
- benztropine (Micromedex) - Includes Dosage Information
- benztropine Injection (Micromedex) - Includes Dosage Information
- Benztropine Mesylate (AHFS DI)
- Benztropine (FDA)
- Benztropine Injection (FDA)
- Benztropine Mesylate (Wolters Kluwer)
Search Again
